Effect of Breathing Exercises on Pain, Dyspnea, and Function in Terminal-Stage Cancer Patients
1 other identifier
interventional
58
1 country
1
Brief Summary
This study aims to evaluate the effects of supervised breathing exercises on pain, dyspnea, and functionality in terminal-stage cancer patients receiving palliative care. Participants in the intervention group receive diaphragmatic and pursed-lip breathing exercises under the guidance of a physiotherapist, while the control group receives only an educational brochure. The study compares pre- and post-intervention outcomes between both groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2025
CompletedFirst Submitted
Initial submission to the registry
May 23, 2025
CompletedFirst Posted
Study publicly available on registry
September 10, 2025
CompletedSeptember 10, 2025
September 1, 2025
9 months
May 23, 2025
September 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
dyspnea
Dyspnea severity will be assessed using the Edmonton Symptom Assessment System - revised (ESAS-r) dyspnea item. This is a numeric rating scale ranging from 0 to 10, where 0 indicates no shortness of breath and 10 indicates the worst possible shortness of breath. The outcome will evaluate changes in dyspnea severity following a structured breathing exercise intervention.
From enrollment to the end of treatment at 1 weeks
Functionality
Functionality will be measured using the Edmonton Symptom Assessment System - revised (ESAS-r) physical well-being domain. The ESAS-r is a validated self-report instrument in which patients rate symptom severity on a scale from 0 to 10, with 0 indicating no impairment and 10 indicating the worst possible level of functional impairment. This outcome assesses changes in participants' ability to perform daily activities such as walking, dressing, and self-care.
From enrollment to the end of treatment at 1 weeks
Study Arms (2)
Diaphragmatic and pursed-lip breathing exercises supervised by a physiotherapist
EXPERIMENTALParticipants in this arm receive supervised breathing exercises performed with a physiotherapist, focusing on diaphragmatic and pursed-lip breathing techniques.
Brochure Education Only
ACTIVE COMPARATORParticipants in this arm receive an informational brochure that explains breathing exercises, but no supervised exercise is provided.
Interventions
Diaphragmatic and pursed-lip breathing exercises supervised by a physiotherapist.
A brochure providing education about breathing exercises for cancer patients.
Eligibility Criteria
You may qualify if:
- Patients receiving palliative care, who are part of this treatment process and considered eligible for the study.
- Patients diagnosed with Stage 4 cancer, included in the study due to their advanced cancer stage.
- Patients with oxygen saturation levels below 95% in room air, who are deemed appropriate for monitoring respiratory function due to this condition.
- Participants must be able to effectively communicate during the study period.
- Individuals who agree to participate in the study must provide written or verbal consent, which is a mandatory criterion for ethical compliance.
You may not qualify if:
- Patients who are unconscious and unable to participate in the study. Individuals under the age of 18.
- Patients dependent on a ventilator.
- Patients with serious health issues, such as uncontrolled hypertension and dyspnea.
- Patients with other significant health problems that prevent participation in the research program.
- Patients with medical conditions requiring drainage treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Atlas Universitylead
Study Sites (1)
Eyupsultan State Hospital
Istanbul, 34500, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yaşar Gül BALTACI, Prof. Dr.
İstanbul Atlas University, Department of Physical Medicine and Rehabilitation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapist
Study Record Dates
First Submitted
May 23, 2025
First Posted
September 10, 2025
Study Start
August 4, 2024
Primary Completion
May 15, 2025
Study Completion
May 15, 2025
Last Updated
September 10, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- The intervention will be applied for 1 week per participant. Respiratory exercises will be conducted daily for 5 consecutive days. Baseline and post-intervention assessments will be performed at the beginning and end of the week, respectively.
- Access Criteria
- De-identified individual participant data (IPD) may be made available upon reasonable request for academic or research purposes. Access requires submission of a detailed proposal and prior approval by the study investigator. Requests can be sent to yildiz.fatmanur@hotmail.com.
This clinical trial evaluates the effects of structured respiratory exercises on pain, dyspnea, and physical functionality in terminal-stage cancer patients under palliative care. It is a single-arm interventional study with pre- and post-intervention assessments. Participants perform pursed-lip and diaphragmatic breathing exercises under physiotherapist supervision for one week. The primary outcomes are changes in pain and dyspnea, measured using ESAS-r and CDS. Secondary outcomes include functional status assessed via standardized tools. Data are collected at baseline and after the intervention. The study follows the Declaration of Helsinki and has received institutional ethical approval. Results aim to support the use of non-pharmacological methods in enhancing the quality of life for patients in end-of-life care.